4/20/12 Contest Update
GSK’s hostile takeover bid for HGSI juiced the biotech sector but the broad market, as measured by the Nasdaq Composite Index, was unable to scratch out a gain for the week. At Friday’s close, the Contest median was up 17.44% YTD (vs. up 15.48% YTD a week ago). In comparison, the Nasdaq Biotech Index was up 16.78% YTD (vs. up 13.11% YTD a week ago), while the Nasdaq Composite Index was up 15.17% YTD (vs. up 15.59% YTD a week ago).
Remarkably, my own portfolio, up 50.95% YTD, remained in first place, with BIOJIM’s portfolio, up 49.59% YTD, holding on to second place and DON’s portfolio, up 39.59% YTD, still in third place.
At Friday's close, 3 of the 38 Contest portfolios were still in the red and 21 of the 38 portfolios were beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
(Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables, when posted.)
Portfolio adjustments: None.
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
4/20/12
Rank Name Profit/Loss
1 BULBA 50,945
2 BIOJIM 49,591
3 DONS 39,585
4 BIOMAV 32,414
5 SCARAM 30,957
6 NP1986 30,502
7 BIOFISH 28,824
8 ARTHUR 27,510
9 ROBO 27,336
10 LJM 26,650
Week's Top 5 Gainers
Symbol 4/13/12 4/20/12 Wk. %chg.
ISR 0.39 0.51 31.54%
SQNM 3.99 5.01 25.56%
NPC.TO 0.22 0.27 22.73%
UBI.AX 0.66 0.80 21.21%
BDSI 2.93 3.53 20.48%
Week's Top 5 Losers
Symbol 4/13/12 4/20/12 Wk. %chg.
HALO 11.27 8.07 -28.39%
ARNA 2.88 2.17 -24.52%
AMRS 3.83 3.02 -21.15%
AVII 1.04 0.88 -15.38%
ALHYG.PA1.53 1.36 -11.11% |
